• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • MANUFACTURERS
  • HEADHUNTERS
  • PRODUCT SECTIONS
  • COMPANIES

SPINEMarketGroup

Spine Industry News

  • HOME
  • 2025
  • 2024
  • BROCHURES
  • ARTICLES
  • VIDEOS

NuVasive Reports Fourth Quarter And Full Year 2018 Financial Results

February 21, 2019 By SPINEMarketGroup

SAN DIEGO, Feb. 20, 2019 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced financial results for the quarter and full year ended Dec. 31, 2018.

Fourth Quarter 2018 Highlights:

Revenue increased 6.3% to $288.3 million, or 6.9% on a constant currency basis;
GAAP operating profit margin of 9.0%; Non-GAAP operating profit margin of 16.0%; and
GAAP diluted earnings per share of $0.23; Non-GAAP diluted earnings per share of $0.69.
Full Year 2018 Highlights:

Revenue increased 7.3% to $1,101.7 million, or 7.1% on a constant currency basis;
GAAP operating profit margin of 4.9%; Non-GAAP operating profit margin of 15.1%; and
GAAP diluted earnings per share of $0.24; Non-GAAP diluted earnings per share of $2.23.
“NuVasive delivered strong year-over-year revenue growth of more than 7% in 2018, demonstrating the Company’s ability to take share in a stable but relatively flat U.S. spine market. Additionally, we made significant progress at our West Carrollton manufacturing facility, exiting the year at 70% SKU rationalization. Collectively, these achievements serve to advance our mission to bring disruptive technology to surgeon partners to enable better, more predictable patient outcomes,” said J. Christopher Barry, chief executive officer of NuVasive. “In 2019, NuVasive will focus on continuing to deliver above market revenue growth, while balancing operating leverage with reinvestment opportunities. We will demonstrate a disciplined approach toward funding key areas for long-term Company growth—furthering our product leadership in global implant systems, accelerating our Surgical Intelligence platform, and investing in surgeon training and education with an ongoing focus on globalization efforts.”

A full reconciliation of non-GAAP to GAAP measures can be found in the tables of this news release.

Fourth Quarter 2018 Results

NuVasive reported fourth quarter 2018 total revenue of $288.3 million, a 6.3% increase on a reported basis and 6.9% increase on a constant currency basis, compared to $271.2 million for the fourth quarter 2017.

For the fourth quarter 2018, GAAP and non-GAAP gross profit was $202.2 million, and GAAP and non-GAAP gross margin was 70.1%. These results compared to GAAP and non-GAAP gross profit of $195.9 million and $196.3 million, respectively, and GAAP and non-GAAP gross margin of 72.2% and 72.4%, respectively for the fourth quarter 2017. Total GAAP and non-GAAP operating expenses for the fourth quarter 2018 were $176.3 million and $156.2 million, respectively. These results compared to GAAP and non-GAAP operating expenses of $166.5 million and $146.9 million, respectively, for the fourth quarter 2017.

The Company reported GAAP net income of $12.2 million, or $0.23 per share, for the fourth quarter 2018 compared to GAAP net income of $23.5 million, or $0.45 per share, for the fourth quarter 2017. On a non-GAAP basis, the Company reported net income of $36.1 million, or $0.69 per share, for the fourth quarter 2018 compared to net income of $29.1 million, or $0.56 per share, for the fourth quarter 2017.

Full Year 2018 Results

NuVasive reported full year 2018 total revenue of $1,101.7 million, a 7.3% increase on a reported basis and 7.1% increase on a constant currency basis, compared to $1,026.7 million for the full year 2017.

Total GAAP and non-GAAP gross profit for the full year 2018 was $790.6 million and $791.6 million, respectively, and GAAP and non-GAAP gross margin was 71.8% and 71.9%, respectively. These results compared to gross profit of $758.2 million and $758.8 million on a GAAP and non-GAAP basis, respectively, and a GAAP and non-GAAP gross margin of 73.9% for the full year 2017. Total GAAP and non-GAAP operating expenses for the full year 2018 were $736.4 million and $624.8 million, respectively. These results compared to GAAP and non-GAAP operating expenses of $646.8 million and $589.5 million, respectively, for the full year 2017.

The Company reported GAAP net income of $12.5 million, or $0.24 per share, for the full year 2018 compared to GAAP net income of $81.6 million, or $1.48 per share, for the full year 2017. On a non-GAAP basis, the Company reported net income of $116.6 million, or $2.23 per share, for the full year 2018 compared to net income of $99.0 million, or $1.89 per share, for the full year 2017.

Annual Financial Guidance for 2019
The Company estimates revenue for full year 2019 to be in the range of $1.14 billion to $1.16 billion, reflecting reported growth in the range of 3.5% to 5.5%. The Company expects currency to have a negative impact in 2019 of approximately $4 million. The Company estimates full year 2019 net income on a GAAP basis in the range of $1.00 to $1.10 per share and non-GAAP earnings per share in the range of $2.20 to $2.30.

(Visited 33 times, 7 visits today)

Filed Under: 2019, NEWS Tagged With: NEWS, RESULTS

Primary Sidebar

PLATINUM SPONSORS

GOLD SPONSORS

MOST POPULAR POSTS

  • Thinking About a Spine Robot? Your 2025 Guide to the…
  • BROCHURES
  • The Crown Is Still Medtronic’s… For Now!
  • Just Reflective, Not Disappointed: Globus Medical’s…
  • What’s Happening with Globus Medical? Why Has the…
  • After Diabetes, Could Medtronic’s Spine…
  • Top Expandable Cages of 2025: Which Lumbar Implants…
  • (UPDATED 2025): Starting Spine Endoscopy? Best…
  • (UPDATED 2024): +8 Lumbar Artificial Discs to Know…
  • Globus Medical to Execute $500 Million Share Buyback…
  • Eminent Spine’s 3D Printed Titanium Pedicle Screw…
  • Dispute Over Spinal Implant Royalties Between…
  • (UPDATED 2024): +108 Stand-Alone Cervical Cages to Know..!
  • (Updated!) 15 Expandable PLIF Cages to Know…!
  • Stryker’s Spine Business Sale: A Smart Move or a…
  • (UPDATED 2025): 6 Artificial Cervical Discs You’ll…
  • Globus Medical Reports First Quarter 2025 Results
  • Orthofix Discontinues M6-C™ and M6-L™ Artificial…
  • Viscogliosi Brothers Completes Acquisition of U.S.…
  • A New Player in Spinal Care, POWEHI Medical!
  • LAST 10 VIDEOS PUBLISHED

    1. Alphatec Spine: ATEC PTP™ Corpectomy
    2. XACT ACE® Robotic System
    3. Perlove Medical: Spine Surgery Robot
    4. FUTURTEC: ORTHBOT Spinal ROBOT
    5. Biedermann Motech: MOSS 100 (Short)
    6. POWEHI MEDICAL AG: KUDOS™ Modular
    7. POWEHI MEDICAL AG: TANTO® Screw
    8. Syntropiq: Taurus TLIF (Short)
    9. LEM Surgical: Dynamis Surgical Robot
    10. Aegis Spine:PathLoc-TA

    Recent Comments

    • Maurus Stoeckli on (UPDATED 2025): Starting Spine Endoscopy? Best Companies to Consider and Why the Market Is Heating Up!
    • Peter on Thinking About a Spine Robot? Your 2025 Guide to the Best Models, What’s Coming, Why You Need One, and Which Is Truly the Best?
    • Daniel on Thinking About a Spine Robot? Your 2025 Guide to the Best Models, What’s Coming, Why You Need One, and Which Is Truly the Best?
    • Peter on A New Player in Spinal Care, POWEHI Medical!
    • Sandy on Just Reflective, Not Disappointed: Globus Medical’s Bittersweet Q1 2025
    • SPINEMarketGroup on M6 Discontinued: What Are the Alternatives for a Cervical Artificial Disc?
    • Email
    • Twitter
    • YouTube

    Subscribe to Our Newsletter!

    Check your inbox or spam folder to confirm your subscription.

    Footer

    • Email
    • Twitter
    • YouTube

    Contact us:

    [email protected] [email protected]

    PRIVATE POLICY

    • Legal Advice
    • VIDEOS

    Copyright © 2025 · SPINEMarketGroup

    Manage Cookie Consent
    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
    Functional Always active
    The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
    Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
    View preferences
    {title} {title} {title}